Researchers suggest osmotic therapy device for spinal cord injuries

The 'e-Taste' interface employs sensors and wireless chemical dispensers to enable remote taste perception, often known as gestation. Field testing done by researchers at The Ohio State University confirmed the device's ability to digitally simulate a range of taste intensities, while still offering variety and safety for the user.

A COVID-19 diagnosis is no longer as frightening as it used to be, thanks to developments in treatment choices. However, a new study reveals that leukocyte (white blood cell) count may now be used to identify who is more likely to develop more significant disease symptoms.

A study by Van Andel Institute scientists suggests that restricting cancer cells' access to fat may enhance the effectiveness of certain cancer treatments.

The matter of what causes complicated neurological disorders like Alzheimer's or multiple sclerosis continues to perplex scientists and doctors, with unknowns impeding early diagnosis and successful treatment.

Columbia researchers developed probiotic bacteria that train the immune system to eliminate cancer cells, paving the way for a new class of cancer vaccinations that take advantage of bacteria's innate tumour-targeting abilities. These microbial cancer vaccines can be tailored to each person's specific original tumour and metastases, perhaps preventing future recurrences.

Researchers at Colorado State University discovered an alternative way for studying alterations during the DNA replication process in lab settings using genetically modified yeast. The novel methodology provides a clearer picture than current pharmacological methods for understanding cell cycle arrest, a fundamental mechanism critical to cancer treatment and genetic concerns.

The significance of gamma-delta T cells in 33 different cancer types is revealed in a recent study that was published in Cell Press. This information sheds light on the cells' potential as clinical biomarkers and therapeutic targets in the treatment of cancer. This thorough examination, which was carried out under the direction of a group of Moffitt Cancer Center experts, marks a substantial breakthrough in our knowledge of these distinct immune cells and how they affect cancer therapy outcomes for patients.

A recent study by researchers at the University of Arizona College of Medicine - Phoenix and the University of California Davis Health discovered a new target for developing a medication to treat atrial fibrillation, the most prevalent kind of irregular heart rhythm.

A group of researchers from the University of Cincinnati has discovered a possible novel approach to enhance the efficacy of radiation therapy and enhance the prognosis of patients with lung cancer metastasizing to the brain.

Approximately 20 per cent of women, who have recurrent pregnancy loss, test positive for a particular antibody that attacks the mother's own body.